Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care

Clinical Journal of Pain

Volumn 25, Issue 9, 2009, Pages 781-785

  Doehring, Alexandra ^a   Freynhagen, Rainer ^b,c   Griessinger, Norbert ^d   Zimmermann, Michael ^e   Sittl, Reinhard ^d   Hentig, Nils Von ^a   Geisslinger, Gerd ^a   Lötsch, Jörn ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Critical Care Medicine   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

GCH1 haplotype; Genetics; Outpatient; Pain therapy

Indexed keywords

BUPRENORPHINE; DIHYDROCODEINE; DIPYRONE; FENTANYL; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HYDROMORPHONE; LEVOMETHADONE; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PIRITRAMIDE; TILIDINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; 5,6,7,8-TETRAHYDROBIOPTERIN; ANALGESIC AGENT; BIOPTERIN; DRUG DERIVATIVE; NARCOTIC ANALGESIC AGENT; TETRAHYDROBIOPTERIN;

ADULT; AGED; ARTICLE; CANCER PAIN; CHRONIC PAIN; CROSS-SECTIONAL STUDY; FACE PAIN; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LOW BACK PAIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; NOCICEPTION; OBSERVATIONAL STUDY; OUTPATIENT CARE; PAIN ASSESSMENT; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT DURATION; UNIVERSITY HOSPITAL; UPREGULATION; AMBULATORY CARE; CLINICAL TRIAL; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PAIN; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANALGESICS; ANALGESICS, OPIOID; BIOPTERIN; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GTP CYCLOHYDROLASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 72149086459     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181b43e12     Document Type: Article

References (27)

1. Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12:1269-1277.
2. Tegeder I, Adolph J, Schmidt H, et al. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain. 2008;12:1069-1077.
3. Auerbach G, Nar H. The pathway from GTP to tetrahydro-biopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem. 1997; 378:185-192.
4. Campbell CM, Edwards RR, Carmona C, et al. Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain. Pain. 2009;141:114-118.
5. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163-W194. (Pubitemid 351664503)
6. Lotsch J, Belfer I, Kirchhof A, et al. Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms. Clin Chem. 2007;53:1010-1015.
7. Nyren P, Lundin A. Enzymatic method for continuous monitoring of inorganic pyrophosphate synthesis. Anal Bio-chem. 1985;151:504-509.
8. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science. 1998;281:363, 365.
9. Shi L, Ho J, Norling LA, et al. A real time quantitative PCR-based method for the detection and quantification of simian virus 40. Biologicals. 1999;27:241-252. (Pubitemid 30077325)
10. Hardy GH. Mendelian proportions in a mixed population. Science. 1908;28:49-50.
11. Twycross R, Wilcock A. Palliative care formulary. 3rd ed. Oxford: Palliativebooks.com; 2007:269.
12. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. San Francisco: Chapman and Hall; 1995.
13. Dahmani S, Dupont H, Mantz J, et al. Predictive factors of early morphine requirements in the post-anaesthesia care unit (PACU). Br J Anaesth. 2001;87:385-389.
14. Solovieva S, Leino-Arjas P, Saarela J, et al. Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain. 2004;109:8-19.
15. Lazarev M, Lamb J, Barmada Pitt Edu MM, et al. Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis? Mol Pain. 2008;4:58.
16. Kim H, Dionne RA. Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans. Mol Pain. 2007;3:6.
17. Oertel B, Lotsch J. Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics. 2008;9:179-194.
18. Doehring A, Antoniades C, Channon KM, et al. Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk. Mutat Res. 2008;659:195-201.
19. Zhang L, Rao F, Zhang K, et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest. 2007;117:2658-2671.
20. Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab. 2001;74:172-185.
21. Thony B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat. 2006;27:870-878.
22. Niederwieser A, Blau N, Wang M, et al. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr. 1984;141:208-214.
23. Vitali SH, Randolph AG. Assessing the quality of case-control association studies on the genetic basis of sepsis. Pediatr Crit Care Med. 2005;6(Suppl 3):S74-S77.
24. Klepstad P, Rakvag TT, Kaasa S, Holthe M, et al. The 118 A>G polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand. 2004;48:1232-1239.
25. Rakvag TT, Klepstad P, Baar C, et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain. 2005;116:73-78.
26. Reyes-Gibby CC, Shete S, Rakvag T, et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain. 2007;130:25-30.
27. Antoniades C, Shirodaria C, Van Assche T, et al. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function. J Am Coll Cardiol. 2008; 52:158-165.